deltatrials
Completed PHASE2 INTERVENTIONAL NCT00175513

V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

Sponsor: Stanley Medical Research Institute

Conditions Psychosis
Interventions Valacyclovir (Valtrex)
Updated 5 times since 2017 Last updated: Apr 12, 2011 Started: Sep 30, 2005 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Psychosis, this trial is completed. The trial is conducted by Stanley Medical Research Institute and has accumulated 5 data snapshots since 2005. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Stanley Medical Research Institute
  • University of British Columbia
Data source: University of British Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations